cirpublications.com-SrvX-1790880680-s425295885 1790880680 Clinical Intelligence Research Press info@cirpublications.com Clinical Intelligence Research Press Journal of Artificial Intelligence for Healthcare Systems J. Artif. Intell. Healthc. Syst. 3149-8981 2025 4 2 Jose Martinez Carmen Lopez 2025 10.68159/s425295885 https://cirpublications.com/pub/journal/1/article/s425295885 Schwab P, Linhardt L, Bauer S, Buhmann JM, Karlen W. Learning counterfactual representations for estimating individual dose-response curves. Proc AAAI Conf Artif Intell. 2020;34(4):5612–9. Bica I, Alaa A, van der Schaar M. Time series deconfounder: estimating treatment effects over time in the presence of hidden confounders. Proc Int Conf Mach Learn (ICML). 2020;119:884–95. Yoon J, Jordon J, van der Schaar M. GANITE: estimation of individualized treatment effects using generative adversarial nets. Int Conf Learn Represent (ICLR). 2018. Hu Y, Huerta J, Cordella N, Mishuris RG, Paschalidis IC. Personalized hypertension treatment recommendations by a data-driven model. BMC Med Inform Decis Mak. 2023;23(1):44. Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30:5998–6008. Melnychuk V, Frauen D, Feuerriegel S. Causal transformer for estimating counterfactual outcomes. Proc Int Conf Mach Learn (ICML). 2022;162:15293–329. Bica I, Alaa AM, Jordon J, van der Schaar M. Estimating counterfactual treatment outcomes over time through adversarially balanced representations. arXiv preprint arXiv:2002.04083. 2020. Lim B. Forecasting treatment responses over time using recurrent marginal structural networks. Adv Neural Inf Process Syst. 2018;31:7493–503. Curth A, Svensson D, Weatherall J, van der Schaar M. Really doing great at estimating CATE? A critical look at ML benchmarking practices in treatment effect estimation. NeurIPS Datasets and Benchmarks Track. 2021:1–12. Künzel SR, Sekhon JS, Bickel PJ, Yu B. Metalearners for estimating heterogeneous treatment effects using machine learning. Proc Natl Acad Sci USA. 2019;116(10):4156–65. Shalit U, Johansson FD, Sontag D. Estimating individual treatment effect: generalization bounds and algorithms. Proc Int Conf Mach Learn (ICML). 2017;70:3076–85. Oikonomou EK, Spatz ES, Suchard MA, Khera R. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials. Lancet Digit Health. 2022;4(11):e796–e805. Bress AP, Greene T, Derington CG, Shen J, Xu Y, Zhang Y, et al. Patient selection for intensive blood pressure management based on benefit and adverse events. J Am Coll Cardiol. 2021;77(16):1977–90. Collier DJ, Taylor M, Godec T, Shiel J, James R, Chowdury Y, et al. Personalized antihypertensive treatment optimization with smartphone-enabled remote precision dosing of amlodipine during the COVID-19 pandemic (PERSONAL-CovidBP Trial). J Am Heart Assoc. 2024;13(4):e030749. Ye X, Zeng QT, Facelli JC, Brixner DI, Conway M, Bray BE. Predicting optimal hypertension treatment pathways using recurrent neural networks. Int J Med Inform. 2020;139:104122. Yi J, Wang L, Song J, Liu Y, Liu J, Zhang H, et al. Development of a machine learning-based model for predicting individual responses to antihypertensive treatments. Nutr Metab Cardiovasc Dis. 2024;34(7):1660–9. Layton AT. AI, machine learning, and ChatGPT in hypertension. Hypertension. 2024;81(4):709–16. Cavero-Redondo I, Martinez-Rodrigo A, Saz-Lara A, Moreno-Herraiz N, Casado-Vicente V, Gomez-Sanchez L, et al. Antihypertensive drug recommendations for reducing arterial stiffness in patients with hypertension: machine learning–based multicohort (RIGIPREV) study. J Med Internet Res. 2024;26:e54357. Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study. PLoS Med. 2018;15(6):e1002584. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. Webster R, Salam A, De Silva HA, Selak V, Stepien S, Rajapakse S, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial. JAMA. 2018;320(6):566–79. Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A. Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(8):1567–73. Mourad JJ, Amodeo C, de Champvallins M, Brzozowska-Villatte R, Asmar R. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension. J Hypertens. 2017;35(7):1481–95. Fleig SV, Weger B, Haller H, Limbourg FP. Effectiveness of a fixed-dose, single-pill combination of perindopril and amlodipine in patients with hypertension: a non-interventional study. Adv Ther. 2018;35(3):353–66. DiPette DJ, Skeete J, Ridley E, Campbell NR, Lopez-Jaramillo P, Kishore SP, et al. Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: clinical perspective and policy implications. J Clin Hypertens. 2019;21(1):4–15. Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124–40. Eadon MT, Kanuri SH, Chapman AB. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment. Expert Rev Precis Med Drug Dev. 2018;3(1):33–47. Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, et al. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36(5):596–624.